Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

180 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Supporting Garraud - and protecting transfusion.
Farrugia A, Grazzini G, Velati C, Liumbruno G. Farrugia A, et al. Transfus Clin Biol. 2020 Feb 19:S1246-7820(20)30034-3. doi: 10.1016/j.tracli.2020.02.003. Online ahead of print. Transfus Clin Biol. 2020. PMID: 32139132 No abstract available.
The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy.
Franchini M, Farrugia A, Velati C, Zanetti A, Romanò L, Grazzini G, Lopez N, Pati I, Marano G, Pupella S, Liumbruno GM. Franchini M, et al. Among authors: Farrugia A. Vox Sang. 2020 Apr 2:10.1111/vox.12928. doi: 10.1111/vox.12928. Online ahead of print. Vox Sang. 2020. PMID: 32240543 Free PMC article. No abstract available.
Faecal immunochemical testing (FIT) in symptomatic patients: what are we missing?
Farrugia A, Widlak M, Evans C, Smith SC, Arasaradnam R. Farrugia A, et al. Frontline Gastroenterol. 2020 Jan;11(1):28-33. doi: 10.1136/flgastro-2018-101174. Epub 2019 May 11. Frontline Gastroenterol. 2020. PMID: 31885837 Free PMC article.
Concerns regarding immunoglobulins.
Farrugia A. Farrugia A. Transfus Apher Sci. 2019 Dec 24:102693. doi: 10.1016/j.transci.2019.102693. Online ahead of print. Transfus Apher Sci. 2019. PMID: 31883802 No abstract available.
Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial.
Mullen M, Jin XY, Child A, Stuart AG, Dodd M, Aragon-Martin JA, Gaze D, Kiotsekoglou A, Yuan L, Hu J, Foley C, Van Dyck L, Knight R, Clayton T, Swan L, Thomson JDR, Erdem G, Crossman D, Flather M; AIMS Investigators. Mullen M, et al. Lancet. 2020 Dec 21;394(10216):2263-2270. doi: 10.1016/S0140-6736(19)32518-8. Epub 2019 Dec 10. Lancet. 2020. PMID: 31836196 Free PMC article. Clinical Trial.
Pharmacokinetics of a new human plasma-derived double virus inactivated and nanofiltered factor IX concentrate in previously treated severe or moderately severe haemophilia B patients.
Castaman G, Borchiellini A, Santagostino E, Tagariello G, Serban M, Uscatescu M, Truica C, Farrugia A, Morfini M. Castaman G, et al. Among authors: Farrugia A. Haemophilia. 2019 Nov;25(6):e364-e367. doi: 10.1111/hae.13828. Epub 2019 Sep 11. Haemophilia. 2019. PMID: 31509326 No abstract available.
Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer.
Perone Y, Farrugia AJ, Rodríguez-Meira A, Győrffy B, Ion C, Uggetti A, Chronopoulos A, Marrazzo P, Faronato M, Shousha S, Davies C, Steel JH, Patel N, Del Rio Hernandez A, Coombes C, Pruneri G, Lim A, Calvo F, Magnani L. Perone Y, et al. Among authors: Farrugia AJ. Nat Commun. 2019 Aug 19;10(1):3791. doi: 10.1038/s41467-019-11801-w. Nat Commun. 2019. PMID: 31427580 Free PMC article.
180 results
Jump to page
Feedback